Correlation Between Merck and GlaxoSmithKline PLC
Can any of the company-specific risk be diversified away by investing in both Merck and GlaxoSmithKline PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and GlaxoSmithKline PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and GlaxoSmithKline PLC ADR, you can compare the effects of market volatilities on Merck and GlaxoSmithKline PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of GlaxoSmithKline PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and GlaxoSmithKline PLC.
Diversification Opportunities for Merck and GlaxoSmithKline PLC
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Merck and GlaxoSmithKline is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and GlaxoSmithKline PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlaxoSmithKline PLC ADR and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with GlaxoSmithKline PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlaxoSmithKline PLC ADR has no effect on the direction of Merck i.e., Merck and GlaxoSmithKline PLC go up and down completely randomly.
Pair Corralation between Merck and GlaxoSmithKline PLC
Considering the 90-day investment horizon Merck Company is expected to generate 0.86 times more return on investment than GlaxoSmithKline PLC. However, Merck Company is 1.16 times less risky than GlaxoSmithKline PLC. It trades about 0.08 of its potential returns per unit of risk. GlaxoSmithKline PLC ADR is currently generating about 0.0 per unit of risk. If you would invest 8,282 in Merck Company on January 21, 2024 and sell it today you would earn a total of 4,296 from holding Merck Company or generate 51.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Merck Company vs. GlaxoSmithKline PLC ADR
Performance |
| Timeline |
| Merck Company |
| GlaxoSmithKline PLC ADR |
Merck and GlaxoSmithKline PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and GlaxoSmithKline PLC
The main advantage of trading using opposite Merck and GlaxoSmithKline PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, GlaxoSmithKline PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline PLC will offset losses from the drop in GlaxoSmithKline PLC's long position.| Merck vs. Alkermes Plc | Merck vs. Ironwood Pharmaceuticals | Merck vs. Deciphera Pharmaceuticals LLC | Merck vs. Eagle Pharmaceuticals |
| GlaxoSmithKline PLC vs. Alkermes Plc | GlaxoSmithKline PLC vs. Ironwood Pharmaceuticals | GlaxoSmithKline PLC vs. Deciphera Pharmaceuticals LLC | GlaxoSmithKline PLC vs. Eagle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |